OCX

Oncocyte (OCX)

Oncocyte Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OCX

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/05/31	05:47	GlobeNewswire Inc.	Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine	NASDAQ:OCX	Oncocyte Corporation
2024/05/24	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/05/24	00:26	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:OCX	Oncocyte Corporation
2024/05/23	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:OCX	Oncocyte Corporation
2024/05/23	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2024/05/23	05:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2024/05/18	06:11	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:OCX	Oncocyte Corporation
2024/05/16	05:05	GlobeNewswire Inc.	Oncocyte Reports First Quarter 2024 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/05/13	21:00	GlobeNewswire Inc.	Oncocyte to Announce First Quarter 2024 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/05/11	06:31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:OCX	Oncocyte Corporation
2024/05/07	22:19	GlobeNewswire Inc.	PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace	NASDAQ:OCX	Oncocyte Corporation
2024/04/12	19:00	GlobeNewswire Inc.	Oncocyte Reports Full Year 2023 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/04/12	10:46	GlobeNewswire Inc.	Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	NASDAQ:OCX	Oncocyte Corporation
2024/04/12	06:30	GlobeNewswire Inc.	Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	NASDAQ:OCX	Oncocyte Corporation
2024/04/10	05:05	GlobeNewswire Inc.	Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/01/24	06:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/01/16	22:00	GlobeNewswire Inc.	Oncocyte to Present at the Sequire Investor Summit in Puerto Rico	NASDAQ:OCX	Oncocyte Corporation
2023/12/06	22:00	GlobeNewswire Inc.	Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays	NASDAQ:OCX	Oncocyte Corporation
2023/11/10	07:19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCX	Oncocyte Corporation
2023/11/09	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2023/11/09	21:00	GlobeNewswire Inc.	Oncocyte Reports Third Quarter 2023 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2023/11/03	21:30	GlobeNewswire Inc.	Oncocyte to Announce Third Quarter 2023 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2023/10/13	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2023/10/11	05:48	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:OCX	Oncocyte Corporation
2023/10/06	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2023/09/20	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2023/08/29	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2023/08/18	07:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2023/08/11	05:50	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCX	Oncocyte Corporation